Q3 2025 13F Holders as of 9/30/2025
-
Type / Class
-
Equity / Common Stock, $0.0001 par value per share
-
Shares outstanding
-
106M
-
Number of holders
-
309
-
Total 13F shares, excl. options
-
86.8M
-
Shares change
-
+3.44M
-
Total reported value, excl. options
-
$1.67B
-
Value change
-
+$93.1M
-
Put/Call ratio
-
1.12
-
Number of buys
-
168
-
Number of sells
-
-205
-
Price
-
$19.27
Significant Holders of Sarepta Therapeutics, Inc. - Common Stock, $0.0001 par value per share (SRPT) as of Q3 2025
474 filings reported holding SRPT - Sarepta Therapeutics, Inc. - Common Stock, $0.0001 par value per share as of Q3 2025.
Sarepta Therapeutics, Inc. - Common Stock, $0.0001 par value per share (SRPT) has 309 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 86.8M shares
of 106M outstanding shares and own 82.18% of the company stock.
Largest 10 shareholders include BlackRock, Inc. (13.2M shares), VANGUARD GROUP INC (10.8M shares), STATE STREET CORP (5.3M shares), Erste Asset Management GmbH (2.69M shares), RENAISSANCE TECHNOLOGIES LLC (2.65M shares), TWO SIGMA INVESTMENTS, LP (2.14M shares), D. E. Shaw & Co., Inc. (2.01M shares), UBS Group AG (1.99M shares), Aberdeen Group plc (1.98M shares), and TWO SIGMA ADVISERS, LP (1.96M shares).
This table shows the top 309 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.